Trials / Completed
CompletedNCT04981275
A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Onegevity Health · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS. Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention study | This observational study will only collect data, not provide any intervention to participants. |
Timeline
- Start date
- 2021-06-19
- Primary completion
- 2022-01-11
- Completion
- 2023-09-30
- First posted
- 2021-07-28
- Last updated
- 2023-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04981275. Inclusion in this directory is not an endorsement.